Sunil Agarwal

Insider Reports History

Entity
Individual
Location
60 Leveroni Court, Novato, CA
Signature
/s/ Jared Freedberg, as attorney-in-fact for Sunil Agarwal
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sunil Agarwal:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARVINAS, INC. Director Common Stock 14.1K $665K $47.05 May 29, 2024 Direct
ARVINAS, INC. Director Stock Option (right to buy) 9.07K $145K $16.00 May 29, 2024 Direct
Sana Biotechnology, Inc. EVP, Head of Development & CMO Stock Options (Right to Buy) 250K Mar 3, 2022 Direct
Astria Therapeutics, Inc. Director Stock Option (Right to Buy) 28.2K Apr 8, 2024 Direct
Calithera Biosciences, Inc. Director Stock Option (Right to Buy) 20K Jun 1, 2022 Direct

Insider Reports Filed by Sunil Agarwal

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARVN ARVINAS, INC. May 29, 2024 2 $0 4 May 31, 2024 Director
ATXS Astria Therapeutics, Inc. Apr 8, 2024 1 $0 4 Apr 9, 2024 Director
ATXS Astria Therapeutics, Inc. Apr 5, 2024 0 $0 3 Apr 9, 2024 Director
ARVN ARVINAS, INC. Jun 15, 2023 2 $0 4 Jun 20, 2023 Director
ARVN ARVINAS, INC. Jun 15, 2023 0 $0 3 Jun 20, 2023 Director
CALA Calithera Biosciences, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
SANA Sana Biotechnology, Inc. Mar 3, 2022 1 $0 4 Mar 8, 2022 EVP, Head of Development & CMO
SANA Sana Biotechnology, Inc. Sep 15, 2021 2 -$1.56M 4 Sep 17, 2021 EVP, Head of Development & CMO
CALA Calithera Biosciences, Inc. Jun 11, 2021 1 $0 4 Jun 14, 2021 Director